Skip to main content
evidena care

Basics

Dronabinol drops and Sativex in Switzerland: what they are

Dronabinol is pure THC that the pharmacy makes as a magistral preparation. Sativex is an authorised oromucosal spray. Both require a narcotics prescription.

Key points

  • Dronabinol is the name of the active substance THC. In Switzerland, pharmacies make dronabinol drops or capsules as a magistral preparation for a specific person; there is no authorised ready-made medicine for it.
  • Sativex is an oromucosal spray with a cannabis extract containing THC and CBD. Swissmedic has authorised it as an add-on therapy for moderate and severe spasticity in multiple sclerosis.
  • Both preparations are subject to the Narcotics Act. The doctor prescribes them on an official narcotics prescription, which is valid for one month.
  • Which preparation in which quantity is suitable is determined solely by the prescribing doctor. This article deliberately contains no dosage information.

Dronabinol drops contain pure THC dissolved in oil. In Switzerland, there is no authorised ready-made medicine for this: a pharmacy makes the drops as a magistral preparation, that is, on a medical prescription for a specific person.1,2

Sativex, by contrast, is an authorised ready-made medicine. The oromucosal spray contains a cannabis extract with THC and CBD and is authorised by Swissmedic as an add-on therapy for moderate and severe spasticity in multiple sclerosis. Both preparations require a narcotics prescription.1,2,6

What is dronabinol?

Dronabinol is the international non-proprietary name for delta-9-tetrahydrocannabinol, THC for short. The Swiss Society for Cannabis in Medicine (SGCM) expressly names THC and dronabinol as synonyms.3

THC acts via the cannabinoid receptors of the body’s own endocannabinoid system. This system is involved in regulating pain processing, stress and appetite. The SGCM describes THC as having, among other things, pain-dampening, antispasmodic and appetite-stimulating properties as well as an effect against nausea. In high doses, THC is intoxicating.3 How well these properties are documented in clinical studies for a particular condition is another question; more on this below.

A preparation with pure THC contains only a single, precisely named active substance. According to the FOPH, ready-to-use cannabis medicines must in any case have a known content of active substance and a defined chemical profile, so that the doctor can set the dosage in a targeted way.1

Dronabinol drops in Switzerland: a magistral preparation

In Switzerland, there is no dronabinol ready-made medicine authorised by Swissmedic. The FOPH counts dronabinol among the medicines exempt from authorisation, the so-called magistral preparations. A public pharmacy or a hospital pharmacy makes them in execution of a medical prescription for a specific person.1,2

The legal basis for this is the Therapeutic Products Act. It exempts medicines made on a medical prescription for a specific person (formula magistralis) from the authorisation requirement.4,2

According to the SGCM, oily solutions or capsules with pure THC (dronabinol) are available in Switzerland, as well as natural cannabis extracts as tinctures and oils. Most are intended to be swallowed or applied in the oral cavity.3 Legally, the FOPH does not restrict the dosage form of magistral preparations. It justifies this with the doctor’s freedom of therapy.1

What swallowed drops mean pharmacologically: THC from the gastrointestinal tract is absorbed slowly and irregularly, and the effect sets in with a delay and lasts longer than with inhalation.7 It is therefore important to follow the doctor’s instructions for use exactly. The article Dosage forms compared explains more about the differences between the forms.

What is Sativex?

Sativex is a spray that is used in the oral cavity. It contains an extract from the cannabis plant with THC and CBD. The SGCM counts it among the two cannabis ready-made medicines registered by Swissmedic in Switzerland; the other is the CBD preparation Epidyolex.3,2

As an authorised medicine, Sativex has a Swiss product information. Among other things, it describes the indication, contraindications, warnings and interactions. The professional information is aimed at professionals, and the patient information at patients. Both are publicly available on Swissmedicinfo.6

What Sativex is authorised for

According to the FOPH, Sativex is authorised in Switzerland as an add-on therapy for moderate and severe spasticity in multiple sclerosis.1,2,6 “Add-on therapy” means: it is used in addition to an existing treatment for the spasticity, not instead of it.

If Sativex is prescribed for this indication, this is use in accordance with the authorisation (on-label). Nothing changed for prescribing by this route with the 2022 change in the law; it was already legal before.1 If Sativex is prescribed for other conditions, this is use outside the authorisation (off-label). The prescribing doctor bears responsibility for this.

Dronabinol and Sativex: the differences at a glance

Dronabinol drops Sativex
Active substance pure THC extract with THC and CBD
Status in Switzerland magistral preparation, not authorised authorised ready-made medicine
Made by pharmacy, for a specific person pharmaceutical company
Use usually an oily solution to swallow spray in the oral cavity
Prescription narcotics prescription narcotics prescription

Sources for the table: FOPH and SGCM.1,3

In terms of efficacy, the two cannot simply be compared. A 2026 Cochrane review on neuropathic pain summarised THC-dominant preparations such as dronabinol and THC/CBD-balanced preparations such as the oromucosal spray separately. For THC-dominant preparations, it found no clear evidence of pain relief of at least 50 percent, with very low certainty of evidence.8 This shows: the fact that a preparation exists says little about how well it has been studied for a particular condition.

Prescription for dronabinol and Sativex: the narcotics prescription

Preparations containing THC are subject to the Narcotics Act. The doctor prescribes them on the official narcotics prescription, and only for patients whom the doctor has examined personally.5,1 Since 1 August 2022, an exceptional authorisation from the FOPH has no longer been required for this.1,3

Among other things, the prescription must contain the name of the medicine, the dosage form, the dosage, the quantity and the instructions for use. It is valid for one month. The prescribed quantity may not exceed the requirement for one month. If circumstances justify it, it may last for at most three months, and the duration of treatment is then stated on the prescription.5

For cannabis medicines that are not prescribed in accordance with their authorisation, which includes dronabinol magistral preparations, the doctor must enter details of the treatment in an FOPH reporting system. For Sativex in accordance with its authorisation, this recording is voluntary according to the SGCM.1,3 The health insurer only covers the costs in individual cases after cost approval. According to the SGCM, this applies both to ready-made medicines and to magistral preparations.3 More on this in the Costs section.

Anyone travelling abroad with a preparation needs additional documents depending on the destination. For the Schengen area, this is explained in the article Schengen certificate for narcotics.

How it works at evidena

At evidena, the doctor decides after the assessment whether cannabis therapy can be considered and which preparation is prescribed. A prescription is not guaranteed. If a prescription is issued, you must fill it within one month of the date of issue. The quantity prescribed generally covers one month, in justified cases at most three months.5

You can book an appointment at portal.evidena.care/appointments. How the assessment works is described on the How it works page. We answer questions via WhatsApp or at info@evidena.care.

Conclusion

Dronabinol is pure THC that the pharmacy makes in Switzerland as a magistral preparation. Sativex is an authorised THC/CBD oromucosal spray for spasticity in multiple sclerosis. Both are only available on a narcotics prescription, and your doctor decides which preparation in which quantity is suitable.

Frequently asked questions

Is dronabinol the same as THC?

Yes. Dronabinol is the name of the active substance delta-9-tetrahydrocannabinol (THC). In Switzerland, it is made as a magistral preparation at the pharmacy, for example as an oily solution or capsule.

What is Sativex authorised for in Switzerland?

As an add-on therapy for moderate and severe spasticity in multiple sclerosis. For other conditions, a prescription would be use outside the authorisation.

Do I need a special prescription for dronabinol drops?

Yes. The doctor prescribes preparations containing THC on the official narcotics prescription. An authorisation from the FOPH has no longer been necessary since 1 August 2022.

How long is the prescription valid?

A narcotics prescription is valid for one month. If circumstances justify it, the doctor can prescribe a quantity for at most three months of treatment.

How many drops should I take?

This is determined exclusively by your doctor and is stated on the prescription as the instructions for use. Do not change the amount yourself, only in agreement with the prescribing practice.

Your situation is individual

Discuss your questions with a doctor.

Book a consultation

Sources

  1. FAQ Cannabisarzneimittel, Bundesamt für Gesundheit BAG, 4. März 2025 (accessed 13 November 2026)
  2. Behandlungsempfehlungen für den Einsatz von Cannabisarzneimitteln, Bundesamt für Gesundheit BAG, 17. Januar 2025 (accessed 13 November 2026)
  3. Allgemeine Informationen zur Anwendung von Medizinalcannabis für Fachpersonen (Fachinformation), Schweizerische Gesellschaft für Cannabis in der Medizin SGCM, ohne Datum (Dateipfad 2024/06), S. 1 bis 3 (accessed 13 November 2026)
  4. Bundesgesetz über Arzneimittel und Medizinprodukte (HMG), SR 812.21, Art. 9 Abs. 2 Bst. a, Fedlex (accessed 13 November 2026)
  5. Betäubungsmittelkontrollverordnung (BetmKV), SR 812.121.1, Art. 46 und 47, Stand am 23. Januar 2023, Fedlex (accessed 13 November 2026)
  6. Fachinformation Sativex, Rubrik «Indikationen/Anwendungsmöglichkeiten», Swissmedicinfo (accessed 13 November 2026)
  7. Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003;42(4):327-360. doi:10.2165/00003088-200342040-00003
  8. Ateş G et al. Cannabis-based medicines for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2026;1(1):CD012182. doi:10.1002/14651858.CD012182.pub3

Written by evidena.care editorial team · Published 13 November 2026 · Reviewed 13 November 2026

This article is general information and does not replace medical advice. Whether cannabis therapy is an option for you is decided by a doctor in a personal consultation.